| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Revenue | $2.32B | +5.4% |
| Cost of Revenue | $1.10B | +8.5% |
| R&D Expense | $300.7M | +13.4% |
| SG&A Expense | $475.7M | -2.0% |
| Operating Income | $748.3M | +6.7% |
| Interest Expense | $57.7M | -11.7% |
| Pre-tax Income | $721.0M | +10.7% |
| Income Tax | $123.9M | +8.3% |
| Net Income | $597.0M |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $337.7M | -20.2% |
| Short-term Investments | $17.4M | -74.9% |
| Accounts Receivable | $270.7M | +18.7% |
| Current Assets | $729.8M | -12.7% |
| Total Assets | $4.30B | +6.1% |
| Current Liabilities | $521.3M | -21.9% |
| Long-term Debt | $1.37B | +0.2% |
| Line Item | 2025-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $726.3M | +3.7% |
| Investing Cash Flow | -$392.8M | -172.2% |
| Financing Cash Flow | -$407.8M | +27.3% |
| +11.2% |
| EPS (Basic) | $15.74 | +11.6% |
| EPS (Diluted) | $15.55 | +11.8% |
| Total Liabilities |
| $2.12B |
| -1.2% |
| Stockholders' Equity | $2.19B | +14.3% |